Larimar Therapeutics, Inc.
NASDAQ:LRMR · NASDAQ Global Market
+$0.04 today
Vol 2.79M · Avg 1.73M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+50.41%
Period High
$5.95
Period Low
$2.42
Latest
$3.64
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Alto Neuroscience, Inc.
NYSE:ANRO
$777.16M
Annexon, Inc.
NASDAQ:ANNX
$587.81M
Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO
$389.86M
DBV Technologies S.A.
NASDAQ:DBVT
$382.97M
Kyverna Therapeutics, Inc.
NASDAQ:KYTX
$350.33M
Amarin Corporation plc
NASDAQ:AMRN
$330.93M
AC Immune S.A.
NASDAQ:ACIU
$241.71M
Altimmune, Inc.
NASDAQ:ALT
$238.74M
Korro Bio, Inc.
NASDAQ:KRRO
$128.80M
enGene Holdings Inc.
NASDAQ:ENGN
$88.06M
What is the latest LRMR filing?
The latest filing shown is 4 dated May 20, 2026.
How many recent filings does LRMR have?
Intrinsic Alpha currently shows 20 recent filings for LRMR.
Explore More
Continue the stock analysis
Jump to another research area for this company.